Kitiwan Rojnueangnit

Kitiwan Rojnueangnit

Auto-generated profile, based on publicly available information

Kitiwan Rojnueangnit

Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Human Mutation
Verified
Journal Article
Open access
PDF file
KRKitiwan Rojnueangnit
Kitiwan Rojnueangnit
JXJing Xie
Jing Xie
AGAlicia Gomes
Alicia Gomes
ASAngela Sharp
Angela Sharp
TCTom Callens
Tom Callens
LMLudwine Messiaen
Ludwine Messiaen
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worldwide. Identification of genotype–phenotype correlations is challenging because of the wide range clinical variability, the progressive nature of the disorder, and extreme diversity of the mutational spectrum. We report 136 individuals with a distinct phenotype carrying one of five different NF1 missense mutations affecting p.Arg1809. Patients presented with multiple café‐au‐lait macules (CALM) with or without freckling and Lisch nodules, but no externally visible plexiform neurofibromas or clear cutaneous neurofibromas were found. About 25% of the individuals had Noonan‐like features. Pulmonic stenosis and short stature were significantly more prevalent compared with classic cohorts (P < 0.0001). Developmental delays and/or learning disabilities were reported in over 50% of patients. Melanocytes cultured from a CALM in a segmental NF1‐patient showed two different somatic NF1 mutations, p.Arg1809Cys and a multi‐exon deletion, providing genetic evidence that p.Arg1809Cys is a loss‐of‐function mutation in the melanocytes and causes a pigmentary phenotype. Constitutional missense mutations at p.Arg1809 affect 1.23% of unrelated NF1 probands in the UAB cohort, therefore this specific NF1 genotype–phenotype correlation will affect counseling and management of a significant number of patients.

5 November 2009 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
PNPracha Nuntnarumit
Pracha Nuntnarumit
KRK Rojnueangnit
K Rojnueangnit
ATA Tangnoo
A Tangnoo

21 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Areerat HnoonualAreerat Hnoonual
Areerat Hnoonual
WTWeerin Thammachote
Weerin Thammachote
TTThipwimol Tim-Aroon
Thipwimol Tim-Aroon
KRKitiwan Rojnueangnit
Kitiwan Rojnueangnit
THTippawan Hansakunachai
Tippawan Hansakunachai
NJNatini Jinawath
Natini Jinawath
Chromosomal microarray (CMA) is now recognized as the first-tier genetic test for detection of copy number variations (CNVs) in patients with autism spectrum disorder (ASD). The aims of this study were to identify known and novel ASD associated-CNVs and to evaluate the diagnostic yield of CMA in Thai patients with ASD. The Infinium CytoSNP-850K BeadChip was used to detect CNVs in 114 Thai patients comprised of 68 retrospective ASD patients (group 1) with the use of CMA as a second line test and 46 prospective ASD and developmental delay patients (group 2) with the use of CMA as the first-tier test. We identified 7 (6.1%) pathogenic CNVs and 22 (19.3%) variants of uncertain clinical significance (VOUS). A total of 29 patients with pathogenic CNVs and VOUS were found in 22% (15/68) and 30.4% (14/46) of the patients in groups 1 and 2, respectively. The difference in detected CNV frequencies between the 2 groups was not statistically significant (Chi square = 1.02, df = 1, P = 0.31). In addition, we propose one novel ASD candidate gene, SERINC2, which warrants further investigation. Our findings provide supportive evidence that CMA studies using population-specific reference databases in underrepresented populations are useful for identification of novel candidate genes.

2 August 2018 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
NVNattariya Vorravanpreecha
Nattariya Vorravanpreecha
TLThanayoot Lertboonnum
Thanayoot Lertboonnum
RRRungrote Rodjanadit
Rungrote Rodjanadit
PSPak Sriplienchan
Pak Sriplienchan
KRKitiwan Rojnueangnit
Kitiwan Rojnueangnit

1 July 2014 in Clinical Dysmorphology
Verified
Journal Article
Closed access
MDMaria Descartes
Maria Descartes
KRKitiwan Rojnueangnit
Kitiwan Rojnueangnit
LCLaura Cole
Laura Cole
ASAmelia Sutton
Amelia Sutton
SMSarah L. Morgan
Sarah L. Morgan
MSMark E. Samuels
Mark E. Samuels

23 February 2015 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
DRDavid Rodriguez‐Buritica
David Rodriguez‐Buritica
KRKitiwan Rojnueangnit
Kitiwan Rojnueangnit
LMLudwine M. Messiaen
Ludwine M. Messiaen
FMFady M. Mikhail
Fady M. Mikhail
NRNathaniel H. Robin
Nathaniel H. Robin